Literature DB >> 14716040

ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus.

Nada Suvajdzic1, Roksanda Stojanovic-Milenkovic, Zoran Tomasevic, Vesna Cemerikic-Martinovic, Biljana Mihaljevic, Henry D E Atkinson.   

Abstract

Patients with systemic lupus erythematosus (SLE) appear to have an increased risk of developing malignancies, especially lymphomas. We report the development of a systemic ALK-negative T-cell anaplastic large cell lymphoma, stage IIB, in a 53-yr-old Caucasian female with a 12-yr history of stable SLE. The patient responded poorly to chemotherapy and died 2 yr after diagnosis. Lymphomas that develop in patients with SLE and other autoimmune diseases are virtually always of B-cell origin. To our knowledge this is the first report of a T-cell anaplastic large cell lymphoma in a patient with SLE. This article discusses the association of SLE and lymphoma, with an emphasis on T-lymphoproliferative states.

Entities:  

Mesh:

Year:  2003        PMID: 14716040     DOI: 10.1385/MO:20:4:409

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  22 in total

Review 1.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Increased risk of cancer in patients with systemic lupus erythematosus.

Authors:  T Pettersson; E Pukkala; L Teppo; C Friman
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

3.  Malignancy in a series of 70 patients with systemic lupus erythematosus.

Authors:  J J Canoso; A S Cohen
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

4.  Impaired Fas response and autoimmunity in Pten+/- mice.

Authors:  A Di Cristofano; P Kotsi; Y F Peng; C Cordon-Cardo; K B Elkon; P P Pandolfi
Journal:  Science       Date:  1999-09-24       Impact factor: 47.728

5.  Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

Authors:  R D Gascoyne; P Aoun; D Wu; M Chhanabhai; B F Skinnider; T C Greiner; S W Morris; J M Connors; J M Vose; D S Viswanatha; A Coldman; D D Weisenburger
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

6.  Haematopoietic cancer and medical history: a multicentre case control study.

Authors:  P Vineis; P Crosignani; C Sacerdote; A Fontana; G Masala; L Miligi; O Nanni; V Ramazzotti; S Rodella; E Stagnaro; R Tumino; C Viganò; C Vindigni; A S Costantini
Journal:  J Epidemiol Community Health       Date:  2000-06       Impact factor: 3.710

7.  Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.

Authors:  L Mellemkjaer; V Andersen; M S Linet; G Gridley; R Hoover; J H Olsen
Journal:  Arthritis Rheum       Date:  1997-04

8.  Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.

Authors:  T Zhou; H Bluethmann; J Eldridge; K Berry; J D Mountz
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

9.  Malignancy in systemic lupus erythematosus: a report of five cases in a series of 96 patients.

Authors:  M Lopez Dupla; M Khamashta; V Pintado Garcia; P Lavilla Uriol; E Valencia Ortega; A Gil Aguado
Journal:  Lupus       Date:  1993-12       Impact factor: 2.911

10.  Characterization of a novel T-cell lymphoma cell line established from a patient with systemic lupus erythematosus-associated lymphoma.

Authors:  S Miyanishi; H Ohno
Journal:  Cancer Genet Cytogenet       Date:  1992-04
View more
  1 in total

1.  Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy.

Authors:  Ken H Young; Dahua Zhang; Jeffery T Malik; Eliot C Williams
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.